2023 Q4 Form 20-F Financial Statement

#000117891324000943 Filed on March 14, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $202.6M $729.7M
YoY Change 35.12% 40.59%
Cost Of Revenue $22.41M $80.65M
YoY Change 29.09% 21.22%
Gross Profit $180.2M $649.1M
YoY Change 35.91% 43.44%
Gross Profit Margin 88.94% 88.95%
Selling, General & Admin $139.4M $531.1M
YoY Change 26.62% 11.24%
% of Gross Profit 77.38% 81.83%
Research & Development $41.90M $156.5M
YoY Change 28.68% 23.18%
% of Gross Profit 23.26% 24.11%
Depreciation & Amortization $2.523M $9.023M
YoY Change -20.74% 5.32%
% of Gross Profit 1.4% 1.39%
Operating Expenses $181.3M $687.6M
YoY Change 27.09% 13.75%
Operating Profit -$1.145M -$38.59M
YoY Change -88.66% -74.62%
Interest Expense $12.86M $41.91M
YoY Change 15.48% 80.0%
% of Operating Profit
Other Income/Expense, Net $41.91M
YoY Change 85.83%
Pretax Income $11.72M $3.326M
YoY Change 1029.8% -102.57%
Income Tax -$621.0K $5.203M
% Of Pretax Income -5.3% 156.43%
Net Earnings $12.34M -$1.877M
YoY Change -929.1% -98.63%
Net Earnings / Revenue 6.09% -0.26%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share $0.24 -$0.04
COMMON SHARES
Basic Shares Outstanding 48.92M 48.37M
Diluted Shares Outstanding 48.37M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.116B $1.116B
YoY Change 25.99% 25.99%
Cash & Equivalents $1.116B $1.116B
Short-Term Investments
Other Short-Term Assets $39.10M $39.10M
YoY Change 3620.55% 58.15%
Inventory
Prepaid Expenses $13.19M
Receivables $17.91M $17.91M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.173B $1.173B
YoY Change 26.98% 26.98%
LONG-TERM ASSETS
Property, Plant & Equipment $99.70M $99.70M
YoY Change 189.69% -13.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.816M $2.816M
YoY Change 381.37% 381.37%
Total Long-Term Assets $102.5M $102.5M
YoY Change -11.01% -11.01%
TOTAL ASSETS
Total Short-Term Assets $1.173B $1.173B
Total Long-Term Assets $102.5M $102.5M
Total Assets $1.276B $1.276B
YoY Change 22.77% 22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.84M $24.84M
YoY Change 238.61% 238.61%
Accrued Expenses $124.9M $124.9M
YoY Change 557.91% 51.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $416.0M $416.0M
YoY Change 39.5% 39.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $46.14M $46.14M
YoY Change -24.47% -24.47%
Total Long-Term Liabilities $46.14M $46.14M
YoY Change -24.47% -24.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $416.0M $416.0M
Total Long-Term Liabilities $46.14M $46.14M
Total Liabilities $462.1M $462.1M
YoY Change 28.62% 28.62%
SHAREHOLDERS EQUITY
Retained Earnings -$584.4M
YoY Change 0.32%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $813.5M $813.5M
YoY Change
Total Liabilities & Shareholders Equity $1.276B $1.276B
YoY Change 22.77% 22.77%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $12.34M -$1.877M
YoY Change -929.1% -98.63%
Depreciation, Depletion And Amortization $2.523M $9.023M
YoY Change -20.74% 5.32%
Cash From Operating Activities $58.50M $215.4M
YoY Change 71.66% 693.74%
INVESTING ACTIVITIES
Capital Expenditures $3.059M $10.46M
YoY Change -30.73% -34.64%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$3.059M -$10.46M
YoY Change -30.73% -44.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.389M $25.29M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.389M 25.29M
YoY Change 74.52% -379.28%
NET CHANGE
Cash From Operating Activities 58.50M 215.4M
Cash From Investing Activities -3.059M -10.46M
Cash From Financing Activities 6.389M 25.29M
Net Change In Cash 61.83M 230.2M
YoY Change 85.54% -25179.96%
FREE CASH FLOW
Cash From Operating Activities $58.50M $215.4M
Capital Expenditures $3.059M $10.46M
Free Cash Flow $55.44M $204.9M
YoY Change 86.9% 1740.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
99999999
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48923903
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47737868
CY2022Q4 mndy Founder Share No Par Value
FounderShareNoParValue
0
CY2022Q4 mndy Founder Share Authorized
FounderShareAuthorized
1
CY2022Q4 mndy Founder Share Outstanding
FounderShareOutstanding
1
CY2023Q4 mndy Founder Share Outstanding
FounderShareOutstanding
1
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30332006
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48366378
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45804714
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30332006
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.99
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.53
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IL
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001845338
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40461
CY2023 dei Entity Registrant Name
EntityRegistrantName
monday.com Ltd.
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
6 Yitzhak Sadeh Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Tel Aviv
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6777506
CY2023 dei Entity Address Country
EntityAddressCountry
IL
CY2023 dei Security12b Title
Security12bTitle
Ordinary shares
CY2023 dei Trading Symbol
TradingSymbol
MNDY
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48923903
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
1197
CY2023 dei Auditor Name
AuditorName
Brightman Almagor Zohar & Co.
CY2023 dei Auditor Location
AuditorLocation
Tel Aviv, Israel
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1116128000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
885894000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
318000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
408000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17911000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13226000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39103000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24725000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1173142000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
923845000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37418000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34416000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62280000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80197000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2816000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
585000 usd
CY2023Q4 us-gaap Assets
Assets
1275656000 usd
CY2022Q4 us-gaap Assets
Assets
1039043000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24837000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7335000 usd
CY2023Q4 mndy Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
106691000 usd
CY2022Q4 mndy Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
73706000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
266284000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
198099000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18201000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19083000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
416013000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
298223000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42946000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
58638000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3189000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2442000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
462148000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
359303000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
99999999
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48923903
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47737868
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 mndy Founder Share No Par Value
FounderShareNoParValue
0
CY2023Q4 mndy Founder Share Authorized
FounderShareAuthorized
1
CY2022Q4 mndy Founder Share Issued
FounderShareIssued
1
CY2023Q4 mndy Founder Share Issued
FounderShareIssued
1
CY2023Q4 mndy Founders Share Value
FoundersShareValue
0 usd
CY2022Q4 mndy Founders Share Value
FoundersShareValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1388108000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1265477000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9804000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3210000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-584404000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-582527000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
813508000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
679740000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1275656000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1039043000 usd
CY2023 us-gaap Revenues
Revenues
729695000 usd
CY2022 us-gaap Revenues
Revenues
519029000 usd
CY2021 us-gaap Revenues
Revenues
308150000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
80645000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
66528000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
39013000 usd
CY2023 us-gaap Gross Profit
GrossProfit
649050000 usd
CY2022 us-gaap Gross Profit
GrossProfit
452501000 usd
CY2021 us-gaap Gross Profit
GrossProfit
269137000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156500000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
127047000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73686000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
438402000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
392068000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
268083000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92733000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
85401000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53493000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
687635000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
604516000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
395262000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-38585000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-152015000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-126125000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41911000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22554000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-838000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3326000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-129461000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-126963000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5203000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7406000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2331000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1877000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136867000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-129294000 usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.99
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.99
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.53
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.53
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48366378
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48366378
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45804714
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45804714
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30332006
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1877000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136867000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-129294000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
4273000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-11386000 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
953000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-8741000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-7582000 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
359000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
13014000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-3804000 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
594000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11137000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-140671000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-128700000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-217557000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5249000 usd
CY2021 mndy Ordinary Stock Value Issued In Vesting And Settlement Of Restricted Stock Units
OrdinaryStockValueIssuedInVestingAndSettlementOfRestrictedStockUnits
0 usd
CY2021 mndy Conversion Of Convertible Preferred Shares To Ordinary Shares Upon Initial Public Offering Value
ConversionOfConvertiblePreferredSharesToOrdinarySharesUponInitialPublicOfferingValue
233496000 usd
CY2021 mndy Stock Issued During Period Value Initial Public Offering And Private Placement Net Of Underwriting Discounts And Commissions And Other Issuance Costs
StockIssuedDuringPeriodValueInitialPublicOfferingAndPrivatePlacementNetOfUnderwritingDiscountsAndCommissionsAndOtherIssuanceCosts
735856000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75051000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
594000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-129294000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
703395000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6133000 usd
CY2022 mndy Ordinary Stock Value Issued In Vesting And Settlement Of Restricted Stock Units
OrdinaryStockValueIssuedInVestingAndSettlementOfRestrictedStockUnits
0 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3681000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107202000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3804000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136867000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
679740000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11666000 usd
CY2023 mndy Ordinary Stock Value Issued In Vesting And Settlement Of Restricted Stock Units
OrdinaryStockValueIssuedInVestingAndSettlementOfRestrictedStockUnits
0 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8782000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
102183000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
13014000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1877000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
813508000 usd
CY2023 mndy Equity Issuance Costs
EquityIssuanceCosts
44995000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9804000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3210000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1877000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136867000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-129294000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9023000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8567000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2746000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-76000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
100186000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
104920000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
73529000 usd
CY2023 mndy Change In Accrued Interest On Revolving Credit Facility
ChangeInAccruedInterestOnRevolvingCreditFacility
0 usd
CY2022 mndy Change In Accrued Interest On Revolving Credit Facility
ChangeInAccruedInterestOnRevolvingCreditFacility
0 usd
CY2021 mndy Change In Accrued Interest On Revolving Credit Facility
ChangeInAccruedInterestOnRevolvingCreditFacility
16000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4685000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4717000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4598000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11840000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6490000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13335000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17397000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16072000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2040000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
14588000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
326000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
24915000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
68932000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
64491000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
64372000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
215404000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27138000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16355000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7901000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16003000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11578000 usd
CY2023 us-gaap Payments For Software
PaymentsForSoftware
2558000 usd
CY2022 us-gaap Payments For Software
PaymentsForSoftware
2998000 usd
CY2021 us-gaap Payments For Software
PaymentsForSoftware
2180000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
129000 usd
CY2023 mndy Changes In Short Term Deposits
ChangesInShortTermDeposits
0 usd
CY2022 mndy Changes In Short Term Deposits
ChangesInShortTermDeposits
0 usd
CY2021 mndy Changes In Short Term Deposits
ChangesInShortTermDeposits
10000000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10459000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19001000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3629000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21243000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12181000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5249000 usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
735856000 usd
CY2023 mndy Receipt Payment Of Tax Advance Relating To Exercises Of Share Options And Restricted Share Units Net And Vesting Of Restricted Share Units
ReceiptPaymentOfTaxAdvanceRelatingToExercisesOfShareOptionsAndRestrictedShareUnitsNetAndVestingOfRestrictedShareUnits
4046000 usd
CY2022 mndy Receipt Payment Of Tax Advance Relating To Exercises Of Share Options And Restricted Share Units Net And Vesting Of Restricted Share Units
ReceiptPaymentOfTaxAdvanceRelatingToExercisesOfShareOptionsAndRestrictedShareUnitsNetAndVestingOfRestrictedShareUnits
-21152000 usd
CY2021 mndy Receipt Payment Of Tax Advance Relating To Exercises Of Share Options And Restricted Share Units Net And Vesting Of Restricted Share Units
ReceiptPaymentOfTaxAdvanceRelatingToExercisesOfShareOptionsAndRestrictedShareUnitsNetAndVestingOfRestrictedShareUnits
22258000 usd
CY2023 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-21000000 usd
CY2023 mndy Capital Lease Payments
CapitalLeasePayments
0 usd
CY2022 mndy Capital Lease Payments
CapitalLeasePayments
84000 usd
CY2021 mndy Capital Lease Payments
CapitalLeasePayments
91000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25289000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9055000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
742272000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
230234000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-918000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
754998000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
885894000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
886812000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131814000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1116128000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
885894000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
886812000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
7560000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
5909000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
3298000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
25000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
62000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
421000 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
105000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
205000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
92000 usd
CY2023 mndy Capitalized Share Based Compensation
CapitalizedShareBasedCompensation
1997000 usd
CY2022 mndy Capitalized Share Based Compensation
CapitalizedShareBasedCompensation
1934000 usd
CY2021 mndy Capitalized Share Based Compensation
CapitalizedShareBasedCompensation
1522000 usd
CY2023 mndy Right Of Use Asset Recognized With Corresponding Leas Liability
RightOfUseAssetRecognizedWithCorrespondingLeasLiability
93000 usd
CY2022 mndy Right Of Use Asset Recognized With Corresponding Leas Liability
RightOfUseAssetRecognizedWithCorrespondingLeasLiability
97289000 usd
CY2021 mndy Right Of Use Asset Recognized With Corresponding Leas Liability
RightOfUseAssetRecognizedWithCorrespondingLeasLiability
0 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>NOTE 1: ORGANIZATION AND DESCRIPTION OF BUSINESS</strong></span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">monday.com Ltd (“monday.com” and together with its subsidiaries collectively, “the Company”) was incorporated under the laws of Israel and commenced operations in 2012. The Company operates a cloud-based visual Work Operating System (‘Work OS’) that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. By using the Company’s Work OS platform and product suite, customers can simplify and accelerate their digital transformation, enhance organizational agility, create a unifying workspace across departments, and increase operational efficiency and productivity.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">monday.com has seven wholly owned subsidiaries: monday.com Inc. (the “U.S. Subsidiary”) incorporated in the United States in 2016, monday.com UK incorporated under the laws of England in 2020, monday.com PTY., incorporated in Australia in 2020, monday.com LTDA. incorporated in Brazil in 2021, monday.com K.K. incorporated in Japan in 2021, monday.com Sp.z.o.o., incorporated in Poland in 2022, and monday.com PTE., incorporated in Singapore in 2022. The subsidiaries primarily engage in providing business development, presale, and customer success services to the Company’s existing and potential customers.</span></p> </div>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div> <table cellpadding="0" cellspacing="0" style="width:100%;font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt"> <tr style="vertical-align:top;font:9pt Arial, Helvetica, Sans-Serif"> <td style="width:0.25in;font:9pt Arial, Helvetica, Sans-Serif"> </td> <td style="width:0.25in;font:9pt Arial, Helvetica, Sans-Serif"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>B.</strong></span></td> <td style="font:9pt Arial, Helvetica, Sans-Serif"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>Use of estimates</strong></span></td> </tr> </table> <p style="margin-top:0pt;margin-bottom:0pt;font:9pt Arial, Helvetica, Sans-Serif"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on assumptions that management considers to be reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates.</span></p> </div>
CY2023 mndy Expenses On Doubtful Accounts
ExpensesOnDoubtfulAccounts
2040000 usd
CY2022 mndy Expenses On Doubtful Accounts
ExpensesOnDoubtfulAccounts
1622000 usd
CY2021 mndy Expenses On Doubtful Accounts
ExpensesOnDoubtfulAccounts
594000 usd
CY2023 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
2130000 usd
CY2022 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
1463000 usd
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
609000 usd
CY2023 us-gaap Lease Cost
LeaseCost
21369000 usd
CY2022 us-gaap Lease Cost
LeaseCost
16396000 usd
CY2021 us-gaap Lease Cost
LeaseCost
4326000 usd
CY2023 us-gaap Severance Costs1
SeveranceCosts1
8435000 usd
CY2022 us-gaap Severance Costs1
SeveranceCosts1
7289000 usd
CY2021 us-gaap Severance Costs1
SeveranceCosts1
4608000 usd
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1898000 usd
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
1551000 usd
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
915000 usd
CY2023 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
198099000 usd
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
134438000 usd
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
70719000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
203235000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
181447000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
143472000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
0 usd
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
4484000 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
3872000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <table cellpadding="0" cellspacing="0" style="width:100%;font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt"> <tr style="vertical-align:top;font:9pt Arial, Helvetica, Sans-Serif"> <td style="width:0.25in;font:9pt Arial, Helvetica, Sans-Serif"> </td> <td style="width:0.25in;font:9pt Arial, Helvetica, Sans-Serif"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>T.</strong></span></td> <td style="font:9pt Arial, Helvetica, Sans-Serif"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>Concentration of Credit Risks</strong></span></td> </tr> </table> <p style="margin-top:0pt;margin-bottom:0pt;font:9pt Arial, Helvetica, Sans-Serif"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents (including money market funds and bank deposits up to three months) and accounts receivable.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">For cash and cash equivalents, the Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. The Company places its cash and cash equivalents with financial institutions with high-quality credit ratings in the United States, Israel, Ireland, Cayman Islands, and Luxembourg and has not experienced any losses in such accounts.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying consolidated balance sheets. For each of the years ended December 31, 2023, and 2022, there were no individual customers that accounted for 10% or more of the Company’s revenues. The Company’s accounts receivable are geographically diversified and derived primarily from sales in the United States, EMEA, and APAC. To manage its accounts receivable risk, the Company evaluates the credit worthiness of its customers and maintains allowances for potential credit losses.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">The Company has not historically experienced any material credit losses related to individual customers or groups of customers in any specific area or industry.</span></p> </div>
CY2023 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<div> <table cellpadding="0" cellspacing="0" style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0;margin-bottom:0;width:100%"> <tr style="vertical-align:top;text-align:justify"> <td style="width:0.25in"> </td> <td style="width:0.25in;text-align:left"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>W.</strong></span></td> <td><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"><strong>Derivative Financial Instruments</strong></span></td> </tr> </table> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">Derivatives are recognized at fair value as either assets or liabilities in the consolidated balance sheets in accordance with ASC 815, Derivatives and Hedging (“ASC 815”). The gain or loss of derivatives which are designated and qualify as hedging instruments in a cash flow hedge, is recorded under accumulated other comprehensive income (loss) and reclassified into earnings</span></p> <div></div> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0"> </p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">in the same period or periods during which the hedged transaction affects earnings. Derivatives are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">The Company’s primary objective for holding derivative instruments is to reduce its exposure to foreign currency rate changes. The Company reduces its exposure by entering into forward foreign exchange contracts and option contracts with respect to operating expenses that are forecasted to be incurred in currencies other than the U.S. dollar. A majority of the Company’s revenues and operating expenditures are transacted in U.S. dollars. However, certain operating expenditures are incurred in or exposed to other currencies, primarily the New Israeli Shekel (“NIS”).</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">The Company has established forecasted transaction currency risk management programs to protect against fluctuations in fair value and the volatility of future cash flows caused by changes in exchange rates. The Company’s currency risk management program includes foreign exchange contracts designated as cash flow hedges. These foreign exchange contracts generally mature within 12 months. See Note 6.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in;text-align:justify"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">In addition, occasionally the Company enters into swaps, options and forward contracts to hedge a portion of its monetary items in the balance sheet, such as cash and cash equivalents balances, denominated in other currencies for short-term periods.</span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in;text-align:justify"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt"> </span></p> <p style="font:9pt Arial, Helvetica, Sans-Serif;margin-top:0pt;margin-bottom:0pt;margin-left:0.25in"><span style="font-family:Arial, Helvetica, Sans-Serif;font-size:9pt">The purpose of these contracts is to protect the fair value of the monetary assets from foreign exchange rate fluctuations. Gains and losses from derivatives related to these contracts are not designated as hedging instruments. The Company does not enter into derivative financial instruments for trading or speculative purposes.</span></p> </div>
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58084000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13189000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13610000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2731000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2268000 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
9806000 usd
CY2023Q4 mndy Short Term Vendor Deposits
ShortTermVendorDeposits
6675000 usd
CY2022Q4 mndy Short Term Vendor Deposits
ShortTermVendorDeposits
3924000 usd
CY2023Q4 mndy Deferred Commission
DeferredCommission
1810000 usd
CY2022Q4 mndy Deferred Commission
DeferredCommission
0 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
408000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1051000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39103000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24725000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55378000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43635000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17960000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9219000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37418000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34416000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8961000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5913000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2746000 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4019000 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
4931000 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3702000 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2558000 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1492000 usd
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
547000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
9693000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
8233000 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4793000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
63440000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
44639000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31810000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18983000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3208000 usd
CY2023Q4 mndy Accrued Expenses Advances From Customers
AccruedExpensesAdvancesFromCustomers
2801000 usd
CY2022Q4 mndy Accrued Expenses Advances From Customers
AccruedExpensesAdvancesFromCustomers
2805000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
8640000 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
4071000 usd
CY2023Q4 mndy Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
106691000 usd
CY2022Q4 mndy Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
73706000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
9806000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
-3208000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
4273000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-11386000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-8741000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-7582000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1801000 usd
CY2023Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
1034464000 usd
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
702680000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18830000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18683000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12439000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8449000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6095000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
64496000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3349000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
61147000 usd
CY2023 mndy Undiscounted Future Payments
UndiscountedFuturePayments
1700000 usd
CY2023 mndy Term Of Lease
TermOfLease
P2Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.035 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036 pure
CY2023 mndy Bank Guarantee To Secure Lease Agreements
BankGuaranteeToSecureLeaseAgreements
6815000 usd
CY2022 mndy Bank Guarantee To Secure Lease Agreements
BankGuaranteeToSecureLeaseAgreements
6871000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
15105000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1564000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
143000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
16812000 usd
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
4318000 usd
CY2023Q4 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P5Y
CY2023 mndy Bank Charges And Other
BankChargesAndOther
443000 usd
CY2022 mndy Bank Charges And Other
BankChargesAndOther
730000 usd
CY2021 mndy Bank Charges And Other
BankChargesAndOther
566000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
62000 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
405000 usd
CY2023 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 usd
CY2022 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 usd
CY2021 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
742000 usd
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
443000 usd
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
792000 usd
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1713000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
361000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
4687000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
0 usd
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
41993000 usd
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18659000 usd
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
875000 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
42354000 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
23346000 usd
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
875000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41911000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22554000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-838000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7847149
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6243273
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1233812
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
721469
CY2023Q4 mndy Shares Available For Future Issuance
SharesAvailableForFutureIssuance
62299717
CY2022Q4 mndy Shares Available For Future Issuance
SharesAvailableForFutureIssuance
59319628
CY2023 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.25 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3800024
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.6
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M15D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
347627000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
207305
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
122.62
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
767148
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.18
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
160929
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
86.35
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3079252
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.82
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M15D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
435699000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2106504
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
32.98
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
329924000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100186000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
104920000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73529000 usd
CY2023 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1997000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5203000 usd
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2282000 usd
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1522000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
102183000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
107202000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
75051000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
194625
CY2023Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
119092
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10368000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-142527000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-132203000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
13694000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
13066000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5240000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3326000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-129461000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-126963000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
557000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
649000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
180000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4646000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
6757000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2151000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5203000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7406000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2331000 usd
CY2023 mndy Effective Income Tax Rate Reconciliation Currency Differences Percent
EffectiveIncomeTaxRateReconciliationCurrencyDifferencesPercent
0 pure
CY2022 mndy Effective Income Tax Rate Reconciliation Currency Differences
EffectiveIncomeTaxRateReconciliationCurrencyDifferences
768000 usd
CY2022 mndy Effective Income Tax Rate Reconciliation Currency Differences Percent
EffectiveIncomeTaxRateReconciliationCurrencyDifferencesPercent
0.01 pure
CY2021 mndy Effective Income Tax Rate Reconciliation Currency Differences
EffectiveIncomeTaxRateReconciliationCurrencyDifferences
18000 usd
CY2021 mndy Effective Income Tax Rate Reconciliation Currency Differences Percent
EffectiveIncomeTaxRateReconciliationCurrencyDifferencesPercent
0 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
765000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29776000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29201000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5294000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.59 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8489000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.07 pure
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
14968000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.12 pure
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
11262000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
3.39 pure
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
14806000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.11 pure
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
10184000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.08 pure
CY2023 mndy Effective Income Tax Rate Reconciliation Of Tax Benefit Relating To Exercise Of Disqualified Iso
EffectiveIncomeTaxRateReconciliationOfTaxBenefitRelatingToExerciseOfDisqualifiedIso
-1408000 usd
CY2023 mndy Effective Income Tax Rate Reconciliation Of Tax Benefit Relating To Exercise Of Disqualified Iso Percentage
EffectiveIncomeTaxRateReconciliationOfTaxBenefitRelatingToExerciseOfDisqualifiedIsoPercentage
-0.42 pure
CY2022 mndy Effective Income Tax Rate Reconciliation Of Tax Benefit Relating To Exercise Of Disqualified Iso
EffectiveIncomeTaxRateReconciliationOfTaxBenefitRelatingToExerciseOfDisqualifiedIso
-1394000 usd
CY2022 mndy Effective Income Tax Rate Reconciliation Of Tax Benefit Relating To Exercise Of Disqualified Iso Percentage
EffectiveIncomeTaxRateReconciliationOfTaxBenefitRelatingToExerciseOfDisqualifiedIsoPercentage
0.01 pure
CY2021 mndy Effective Income Tax Rate Reconciliation Of Tax Benefit Relating To Exercise Of Disqualified Iso
EffectiveIncomeTaxRateReconciliationOfTaxBenefitRelatingToExerciseOfDisqualifiedIso
-3069000 usd
CY2021 mndy Effective Income Tax Rate Reconciliation Of Tax Benefit Relating To Exercise Of Disqualified Iso Percentage
EffectiveIncomeTaxRateReconciliationOfTaxBenefitRelatingToExerciseOfDisqualifiedIsoPercentage
0.02 pure
CY2023 mndy Effective Income Tax Rate Reconciliation Initial Public Offering Costs
EffectiveIncomeTaxRateReconciliationInitialPublicOfferingCosts
-1800000 usd
CY2023 mndy Effective Income Tax Rate Reconciliation Initial Public Offering Costs Percent
EffectiveIncomeTaxRateReconciliationInitialPublicOfferingCostsPercent
-0.54 pure
CY2022 mndy Effective Income Tax Rate Reconciliation Initial Public Offering Costs
EffectiveIncomeTaxRateReconciliationInitialPublicOfferingCosts
-1800000 usd
CY2022 mndy Effective Income Tax Rate Reconciliation Initial Public Offering Costs Percent
EffectiveIncomeTaxRateReconciliationInitialPublicOfferingCostsPercent
0.01 pure
CY2021 mndy Effective Income Tax Rate Reconciliation Initial Public Offering Costs
EffectiveIncomeTaxRateReconciliationInitialPublicOfferingCosts
-5399000 usd
CY2021 mndy Effective Income Tax Rate Reconciliation Initial Public Offering Costs Percent
EffectiveIncomeTaxRateReconciliationInitialPublicOfferingCostsPercent
0.04 pure
CY2023 mndy Effective Income Tax Rate Reconciliation Preferred Technological Enterprise
EffectiveIncomeTaxRateReconciliationPreferredTechnologicalEnterprise
1140000 usd
CY2023 mndy Effective Income Tax Rate Reconciliation Preferred Technological Enterprise Percent
EffectiveIncomeTaxRateReconciliationPreferredTechnologicalEnterprisePercent
0.34 pure
CY2022 mndy Effective Income Tax Rate Reconciliation Preferred Technological Enterprise
EffectiveIncomeTaxRateReconciliationPreferredTechnologicalEnterprise
15523000 usd
CY2022 mndy Effective Income Tax Rate Reconciliation Preferred Technological Enterprise Percent
EffectiveIncomeTaxRateReconciliationPreferredTechnologicalEnterprisePercent
-0.12 pure
CY2021 mndy Effective Income Tax Rate Reconciliation Preferred Technological Enterprise
EffectiveIncomeTaxRateReconciliationPreferredTechnologicalEnterprise
14460000 usd
CY2021 mndy Effective Income Tax Rate Reconciliation Preferred Technological Enterprise Percent
EffectiveIncomeTaxRateReconciliationPreferredTechnologicalEnterprisePercent
-0.11 pure
CY2023 mndy Effective Income Tax Rate Reconciliation Currency Differences
EffectiveIncomeTaxRateReconciliationCurrencyDifferences
0 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
538000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.16 pure
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
790000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
370000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.56 pure
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7406000 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.06 pure
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2331000 usd
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39809000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39942000 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3780000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
9663000 usd
CY2023Q4 mndy Deferred Tax Assets Initial Public Offering Costs
DeferredTaxAssetsInitialPublicOfferingCosts
0 usd
CY2022Q4 mndy Deferred Tax Assets Initial Public Offering Costs
DeferredTaxAssetsInitialPublicOfferingCosts
1800000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5320000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3855000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2093000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1428000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
51002000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
56688000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48430000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
55561000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2572000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1127000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2572000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1127000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2572000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1127000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
331742000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.21 pure
CY2023 mndy Threshold Limit Of Consolidated Revenues Subject To Tax Rate On Income Derived From Intellectual Property
ThresholdLimitOfConsolidatedRevenuesSubjectToTaxRateOnIncomeDerivedFromIntellectualProperty
10000000000
CY2023 mndy Percent Of Tax Rate On Income Derived From Intellectual Property
PercentOfTaxRateOnIncomeDerivedFromIntellectualProperty
0.12 pure
CY2023 mndy Tax Rate Of Development Area
TaxRateOfDevelopmentArea
0.075 pure
CY2023 mndy Minimum Percentage Of Annual Revenues Derived From Exports
MinimumPercentageOfAnnualRevenuesDerivedFromExports
0.25 pure
CY2023 mndy Tax Rate On Dividends Distributed From Income From Preferred Technological Enterprises
TaxRateOnDividendsDistributedFromIncomeFromPreferredTechnologicalEnterprises
0.20 pure
CY2023 mndy Tax Rate On Dividend Distributed To Foreign Corporate Shareholder
TaxRateOnDividendDistributedToForeignCorporateShareholder
0.04 pure
CY2023 mndy Maximum Percentage Of Foreign Investors Defined For Distribution Of Dividend To Foreign Corporate Shareholder
MaximumPercentageOfForeignInvestorsDefinedForDistributionOfDividendToForeignCorporateShareholder
0.90 pure
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1877000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136867000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-129294000 usd
CY2023 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2021 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8203000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1877000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
136867000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
137497000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48366378
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45804714
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30332006
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.99
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.53

Files In Submission

Name View Source Status
0001178913-24-000943-index-headers.html Edgar Link pending
0001178913-24-000943-index.html Edgar Link pending
0001178913-24-000943.txt Edgar Link pending
0001178913-24-000943-xbrl.zip Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_12-3.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_13-3.htm Edgar Link pending
exhibit_15-1.htm Edgar Link pending
exhibit_2-2.htm Edgar Link pending
exhibit_4-8.htm Edgar Link pending
exhibit_8-1.htm Edgar Link pending
exhibit_97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
image00002.jpg Edgar Link pending
image00003.jpg Edgar Link pending
image00007.jpg Edgar Link pending
image1.jpg Edgar Link pending
img101_v1.jpg Edgar Link pending
img102a_v1.jpg Edgar Link pending
img102_v1.jpg Edgar Link pending
img103_v1.jpg Edgar Link pending
img104_v1.jpg Edgar Link pending
img105_v1.jpg Edgar Link pending
img106_v1.jpg Edgar Link pending
img107_v1.jpg Edgar Link pending
img108_v1.jpg Edgar Link pending
img109_v1.jpg Edgar Link pending
img110_v1.jpg Edgar Link pending
img111_v1.jpg Edgar Link pending
img112_v1.jpg Edgar Link pending
img113_v1.jpg Edgar Link pending
img114_v1.jpg Edgar Link pending
img115_v1.jpg Edgar Link pending
img116_v1.jpg Edgar Link pending
img117_v1.jpg Edgar Link pending
img118_v1.jpg Edgar Link pending
img119_v1.jpg Edgar Link pending
img120_v1.jpg Edgar Link pending
img121_v1.jpg Edgar Link pending
img123_v1.jpg Edgar Link pending
img124_v1.jpg Edgar Link pending
img125_v1.jpg Edgar Link pending
img126_v1.jpg Edgar Link pending
img127_v1.jpg Edgar Link pending
img128_v1.jpg Edgar Link pending
img129_v1.jpg Edgar Link pending
img130_v1.jpg Edgar Link pending
img131_v1.jpg Edgar Link pending
img132_v1.jpg Edgar Link pending
img133_v1.jpg Edgar Link pending
img134_v1.jpg Edgar Link pending
img135_v1.jpg Edgar Link pending
img136_v1.jpg Edgar Link pending
img137_v1.jpg Edgar Link pending
img138_v1.jpg Edgar Link pending
img140_v1.jpg Edgar Link pending
img141_v1.jpg Edgar Link pending
img142_v1.jpg Edgar Link pending
img143_v1.jpg Edgar Link pending
img144_v1.jpg Edgar Link pending
img145_v1.jpg Edgar Link pending
img146_v1.jpg Edgar Link pending
img147_v1.jpg Edgar Link pending
img148_v1.jpg Edgar Link pending
img149_v1.jpg Edgar Link pending
img150_v1.jpg Edgar Link pending
img151_v1.jpg Edgar Link pending
img152_v1.jpg Edgar Link pending
img153_v1.jpg Edgar Link pending
img154_v1.jpg Edgar Link pending
img155_v1.jpg Edgar Link pending
img156_v1.jpg Edgar Link pending
img157_v1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mndy-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
mndy-20231231_def.xml Edgar Link unprocessable
mndy-20231231_lab.xml Edgar Link unprocessable
mndy-20231231_pre.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2431098.htm Edgar Link pending
zk2431098_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
mndy-20231231_cal.xml Edgar Link unprocessable